Investors

Shareholder Information

Shareholder Information

General Shareholder Information

1. Listing on Stock Exchanges and Security Codes :
Name of Stock Exchange Security Code
A. Equity shares
BSE Limited, Mumbai (BSE)

500420

National Stock Exchange of India Limited, Mumbai (NSE)

TORNTPHARM

B. Non-Convertible Debentures
National Stock Exchange of India Limited, Mumbai (NSE)

The Company has paid the annual listing fees for the year 2022-23 to both the above stock exchanges.

2. Distribution of shareholding as at 31st March, 2022 :

By size of shareholding :

Category (Shares) Mode of Holding No. of Shares % To Equity No. of Holders % To Holders
1 - 1,000 Electronic 5,469,375 3.23 62,796 96.71
Physical 305,066 0.18 680 1.05
1,001 – 2,000 Electronic 928,013 0.55 631 0.97
Physical 35,200 0.02 22 0.03
2,001 – 10,000 Electronic 2,089,148 1.23 480 0.74
Physical 35,200 0.02 8 0.01
10,001 – 20,000 Electronic 1,224,250 0.72 88 0.14
Physical 0 0.00 0 0.00
Above 20,000 Electronic 159,136,468 94.04 227 0.35
Physical 0 0.00 0 0.00
Total Electronic 168,847,254 99.78 64,222 98.91
Physical 375,466 0.22 710 1.09
  Total 169,222,720 100.00 64,932 100.00

By category of shareholders :

Category

No. of Shares

Total Shares

% of Holding

Electronic

Physical

Promoter's Group 120,564,720 0 120,564,720 71.25
Mutual Fund 12,658,432 0 12,658,432 7.48
Bank, FIs, AIFs & Insurance Companies 134,016 0 134,016 0.08
Foreign Institutional Investors/QIB/QFIs/NRIs 22,396,269 0 22,396,269 13.23
Other Bodies Corporate 795,534 3,400 798,934 0.47
Indian Public 12,116,857 372,066 12,488,923 7.38
IEPF 181,426 0 181,426 0.11
Total 168,847,254 375,466 169,222,720 100.00

3. Market Price Data :

Monthly Share Price movement during the financial year ended 31st March, 2022 at BSE & NSE (Share price in Rs.)
Month BSE NSE
High Low Volume High Low Volume
Apr-21 2,680.00 2,477.65 2,37,171 2,682.00 2,475.50 55,53,674
May-21 2,891.55 2,486.60 3,60,364 2,892.00 2,484.95 81,14,169
Jun-21 3,007.00 2,715.00 2,25,613 3,009.50 2,715.00 52,68,655
Jul-21 3,121.45 2,882.95 2,91,089 3,144.00 2,883.00 49,39,842
Aug-21 3,156.45 2,855.85 1,71,877 3,157.90 2,854.00 38,28,318
Sep-21 3,248.00 3,017.60 5,04,298 3,250.20 3,019.25 25,05,215
Oct-21 3,200.00 2,765.65 2,01,827 3,203.00 2,766.00 27,07,311
Nov-21 3,248.00 2,734.50 3,71,258 3,248.80 2,735.30 69,90,964
Dec-21 3,304.45 2,919.20 1,67,279 3,298.50 2,924.75 53,41,854
Jan-22 3,299.90 2,601.30 1,93,055 3,295.95 2,615.00 58,31,997
Feb-22 2,775.00 2,540.00 1,08,034 2,778.95 2,530.05 39,16,553
Mar-22 2,985.65 2,651.90 62,758 2,987.75 2,651.00 36,94,521
Total 28,94,623   58,693,073
% of volume traded to outstanding shares 1.71%   34.68%

4. Other Information :

a. Dematerialisation of securities :

The equity shares of the Company are traded compulsorily in the dematerialised segment of all the stock exchanges and are under rolling settlement. Approximately 99.78% of the shares have been dematerialised. Shares held by promoters are all in dematerialised form. The demat security (ISIN) code for the equity share is INE685A01028.

b. Share Transfer System :

SEBI vide its circular dated 25th January 2022, has mandated that listed companies shall issue the securities in dematerialized form only, in order to enhance ease of dealing in securities markets by investors, for transactions including Issue of duplicate securities certificate, claim from unclaimed suspense account, renewal / exchange of securities certificate, endorsement, sub-division / splitting of securities certificate, consolidation of securities certificates/folios, transmission and transposition of shares. Accordingly, Shareholders are requested to make service requests by submitting a duly filled and signed Form ISR – 4, the format of which is available on the Company’s website under the link at https://www.torrentpharma.com/index.php/investors/shareHolder . The details of transmission approved by the delegates are noted by the Securities Transfer and Stakeholders Relationship Committee. The Company obtains from a Company Secretary in Practice an annual certificate of compliance with the share transfer formalities as required under Regulation 40(9) of the Listing Regulations and files a copy of the certificate with the Stock Exchanges. The Company has signed necessary agreements with two depositories currently functional in India viz. National Securities Depository Limited & Central Depository Services (India) Limited. The transfer of shares in electronic mode need not be approved by the Company.

The Company has sent individual letters to all the Members holding shares of the Company in physical form for furnishing their PAN, KYC details and Nomination pursuant to the SEBI Circular dated 3rd November, 2021. Attention of the Members holding shares of the Company in physical form is invited to go through the said important communication under the web link at https://www.torrentpharma.com/index.php/investors/shareHolder.

c. Physical Transfers Pending (as on 31-Mar-22):

99.78% of the equity shares of the Company are held in dematerialised form & the handling of physical transfer of shares are minimal.

d. Complaints Pending (as on 31-Mar-22):

During the year, the Company has received 6 (six) complaints from shareholders which were attended within a reasonable period of time. No complaint was pending as on 31st March, 2022.

5. Investor services :

The investor related queries may be addressed to:
investorservices@torrentpharma.com

Registrars & Transfer Agents

KFIN Technologies Limited,
(Attn. Ganesh Chandra Patro – EVP)

Unit: Torrent Pharmaceuticals Limited,
Selenium Building, Tower-B,
Plot No. 31 & 32, Financial District,
Gachibowli, Nanakramguda,
Serilingampally, Hyderabad,
Rangareddy, Telangana – 500 032

Toll Free/ Phone Number: 1800 309 4001,

WhatsApp Number: (91) 910 009 4099

KPRISM (Mobile Application): https://kprism.kfintech.com/

KFINTECH Corporate Website: https://www.kfintech.com

RTA Website: https://ris.kfintech.com

Investor Suppot Center (DIY Link): https://ris.kfintech.com/clientservices/isc

E-mail: einward.ris@kfintech.com

Compliance Officer

Chintan Trivedi,
Company Secretary

Torrent Pharmaceuticals Limited,
Torrent House, Off Ashram Road, Ahmedabad–380 009

Telephone: 91-79-2659 9000
Fax: 91-79-2658 2100

Shareholders holding shares in electronic mode should address their correspondence related to change in their records, viz. address, bank account details, etc., to the depository participant with whom they hold the account.

more... Download

Information to be provided to RTA, if holding shares in physical form

The Securities and Exchange Board of India (‘SEBI’) vide its circular dated 03 rd November 2021 has made it mandatory for the shareholders holding securities in physical form to furnish PAN, KYC details and Nomination to the Registrar and Transfer Agent (‘RTA’) of the Company. In case of failure to provide required documents and details as per the aforesaid SEBI circular, all folios of such shareholders shall be frozen on or after 01 st April 2023 by the RTA. Further SEBI vide its circular dated 14 th December, 2021 has issued clarification with respect to its earlier circular dated 3 rd November, 2021.

Click here for SEBI Circular:https://www.sebi.gov.in/legal/circulars nov-2021/common-and-simplified-norms-for-processing-investor-s-service-request-by-rtas-and-norms-for-furnishing-pan-kyc-details-and-nomination_53787.html and

https://www.sebi.gov.in/legal/circulars/dec-2021/clarifications-with-respect-to-circular-dated-november-03-2021-on-common-and-simplified-norms-for-processing-investor-s-service-request-by-rtas-and-norms-for-furnishing-pan-kyc-details-_54602.html

In view of the above, shareholders of the Company holding securities in physical form shall provide following documents/details to RTA:
  • PAN
  • Nomination (for all eligible folios) in Form No. SH-13 or submit declaration to ‘Opt-out’ in Form ISR-3. Any cancellation or change in nomination shall be provided in Form No. SH-14. Said Forms can be downloaded from the link provided in table at sr no. 5 and 6 respectively.
  • Contact details including Postal address with PIN code, Mobile Number, E-mail address
  • Bank Account details including Bank name and branch, Bank account number, IFS code
  • Specimen signature

The above documents/details are to be provided in hard copy to Company’s RTA i.e. KFin Technologies Private Limited, Selenium Tower B, Plot No.31-32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad 500 032, Telangana, India or through electronic mode with e-signature through email at einward.ris@kfintech.com along with Name and folio numbers.

Further, SEBI vide its circular dated January 25, 2022, has mandated that listed companies  shall  issue  the securities  in  dematerialized  form  only, in order to enhance ease of dealing in securities markets by investors, for transactions including Issue of duplicate securities certificate, claim from unclaimed suspense account, renewal / exchange of securities certificate, endorsement, sub-division / splitting of securities certificate, consolidation of securities certificates/folios, transmission and transposition of shares.

In view of the above, the securities holder/claimant shall submit duly filled up Form ISR-4 which can be downloaded on the link provided on below table at sr.no. 4 along with the documents / details specified in the SEBI Circular.

Click here for SEBI Circular:https://www.sebi.gov.in/legal/circulars/jan-2022/issuance-of-securities-in-dematerialized-form-in-case-of-investor-service-requests_55542.html

The shareholders can download the forms mentioned in SEBI circular as given below:

Sr. No. Form Purpose Download Form
1 Form ISR-1 Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical form) Download Form
2 Form ISR-2 Confirmation of Signature of securities holder by Banker Download Form
3 Form ISR-3 Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies Download Form
4 Form ISR-4 Request for issue of Duplicate Certificate and other Service Requests Download Form
5 Form SH-13 Nomination Form Download Form
6 Form SH-14 Cancellation or Variation of Nomination Download Form

For SEBI Circular dated May 30, 2022 relating to Standard Operating Procedures (SOP) for dispute resolution under the Stock Exchange arbitration mechanism for disputes between a Listed Company and/or Registrars to an Issue and Share Transfer Agents (RTAs) and its Shareholder(s)/Investor(s), Click here.